SMO mutations confer poor prognosis in malignant pleural mesothelioma.
Signorelli D, Proto C, Botta L, Trama A, Tiseo M, Pasello G, Lo Russo G, Fabbri A, Imbimbo M, Busico A, Prelaj A, Ferrara R, Galli G, De Toma A, Tamborini E, Pastorino U, de Braud F, Gatta G, Garassino MC, Ganzinelli M.
Signorelli D, et al. Among authors: ferrara r.
Transl Lung Cancer Res. 2020 Oct;9(5):1940-1951. doi: 10.21037/tlcr-19-425.
Transl Lung Cancer Res. 2020.
PMID: 33209614
Free PMC article.